U.S., April 18 -- ClinicalTrials.gov registry received information related to the study (NCT07536412) titled 'Decision Aid Efficacy in Low Risk Thyroid Cancer' on April 02.
Brief Summary: Low-risk thyroid cancer grows very slowly. More than 99% of patients with this cancer survive for at least 5 years. There are 3 main treatment options: remove the whole thyroid, remove just the part of the thyroid with the cancer in it, or leave the cancer in the thyroid and monitor it. Survival is similar across the 3 main treatment options. It can be difficult for patients to choose a treatment option, especially when feeling anxious about the cancer diagnosis. In this study, enrolled patients will receive a decision aid after finding out they have canc...